Evidence map›Paper›PMID 34716170›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2022

Successful treatment of Verona integron-encoded metallo-β-lactamase-producing

Ana Pelaez Bejarano, Raquel Sánchez-Del Moral, Olalla Montero-Pérez, Francisco Javier Martínez-Marcos

Open access · greenAbstract read
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic.European respiratory review : an official journal of the European Respiratory Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ana Pelaez BejaranoUnidad de Gestión Clínica Farmacia Hospitalaria, Hospital Juan Ramon Jimenez, Huelva, Spain pelaezana21l@gmail.com.ORCID 0000-0001-8508-0481
Raquel Sánchez-Del MoralUnidad de Gestión Clínica Farmacia Hospitalaria, Hospital Juan Ramon Jimenez, Huelva, Spain.
Olalla Montero-PérezUnidad de Gestión Clínica Farmacia Hospitalaria, Hospital Juan Ramon Jimenez, Huelva, Spain.
Francisco Javier Martínez-MarcosUnidad de Gestión Clínica Enfermedades Infecciosas, Hospital Juan Ramon Jimenez, Huelva, Spain.
Hospital Juan Ramón Jiménez · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The case of a female who had an accident that caused an open fracture is reported. During hospitalisation, Verona integron-encoded metallo-β-lactamase (VIM)-producing

Indexed as

AztreonamCeftazidimeAzabicyclo Compoundsbeta-LactamasesDrug CombinationsFemaleHumansIntegronsKlebsiella pneumoniaeMicrobial Sensitivity Testsavibactamavibactam, ceftazidime drug combinationAzabicyclo CompoundsAztreonambeta-LactamasesCeftazidimeDrug Combinationscase reportscommunicable diseasescontinuingdrug monitoringeducationpharmaceutical preparationspharmacy

Identifiers

PMID34716170
PMCPMC8899665
OpenAlexW3209620449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.